Gordon Hurst to become Chair of Darktrace
CAMBRIDGE, United Kingdom, March 25, 2021 /PRNewswire/ — Darktrace, a leading autonomous cyber security AI company,…
CAMBRIDGE, United Kingdom, March 25, 2021 /PRNewswire/ — Darktrace, a leading autonomous cyber security AI company,…
LONDON, March 25, 2021 /PRNewswire-PRWeb/ — TORA, the provider of industry leading trading technology, has…
MANCHESTER, England, March 25, 2021 /PRNewswire/ — Healum, a leading digital health company, known for…
NEW YORK and LONDON, March 25, 2021 /PRNewswire/ — Despite its new obligations for financial…
LONDON, March 25, 2021 /PRNewswire/ — Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today…
NANTES, France and TEL AVIV, Israel, March 25, 2021 /PRNewswire/ — Expandium (a VIAVI Solutions company, NASDAQ:…
TRONDHEIM, Norway, Mar. 25, 2021 /PRNewswire-PRWeb/ — Nomono, a spatial audio research firm based in Trondheim,…
TEL AVIV, Israel, March 25, 2021 /PRNewswire/ — IMPROVATE’s CleanTech and Renewable Energy international conference…
SAN JOSE, Calif., March 25, 2021 /PRNewswire/ — Lumentum Holdings Inc. (“Lumentum”) today announced that Coherent,…
SANTA CLARA, Calif., March 25, 2021 /PRNewswire/ — Frost & Sullivan’s recent analysis, Communications and…
CONVENING OF THE ORDINARY GENERAL MEETINGS OF SHAREHOLDERS OF 30 APRIL 2021 The shareholders are invited…
Topline data expected in the first half of 2021 UNIONDALE, N.Y., March 25, 2021 (GLOBE…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL…
Comprehensive Test Helps Identify Women with Advanced Ovarian Cancer Who May Benefit from First-Line Lynparza®…
UTRECHT, The Netherlands and PHILADELPHIA, March 24, 2021 (GLOBE NEWSWIRE) — LAVA Therapeutics B.V. (Nasdaq:…
LOS ANGELES, March 24, 2021 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) – Seraph Research Institute (SRI)…
SOUTH SAN FRANCISCO, Calif., March 24, 2021 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP),…
NEW HAVEN, Conn., March 24, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSX.V:BTI; OTCQB:BIOAF;), (“Bioasis” or…
2020 marked a year of successful evolution to a chemoprotection oncology company focused on fundamentally…
– Initial data from Phase 1/2a trial of EOS-448 to be presented at American Association…